Literature DB >> 19356105

Synthesis of haloperidol prodrugs and their hydrolysis by porcine liver esterase.

Andrew P Morris1, Keith R Brain, Charles M Heard.   

Abstract

In probing enhancement of the transdermal delivery of the anti-psychotic drug haloperidol, five prodrugs (ethanoate, propanoate, butanoate, octanoate and decanoate) were synthesised and their relative rates of hydrolysis determined in the presence of porcine liver esterase (PLE), a model for cutaneous esterases. (1)H NMR, MS and elemental analysis confirmed the successful synthesis of each prodrug in high purity, and each was found to hydrolyse in the presence of PLE with the hydrolytic rate reaching a maximum with haloperidol octanoate (C8) at 2.31 +/- 0.06 nmol ml(-1) h(-1) (p < 0.001).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19356105     DOI: 10.2174/187231208786734111

Source DB:  PubMed          Journal:  Drug Metab Lett        ISSN: 1872-3128


  3 in total

1.  Third-Generation Sequencing and Analysis of Four Complete Pig Liver Esterase Gene Sequences in Clones Identified by Screening BAC Library.

Authors:  Qiongqiong Zhou; Wenjuan Sun; Xiyan Liu; Xiliang Wang; Yuncai Xiao; Dingren Bi; Jingdong Yin; Deshi Shi
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

2.  Pig liver esterases PLE1 and PLE6: heterologous expression, hydrolysis of common antibiotics and pharmacological consequences.

Authors:  Qiongqiong Zhou; Qiling Xiao; Yongliang Zhang; Xiliang Wang; Yuncai Xiao; Deshi Shi
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

3.  Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo.

Authors:  Hiran A Prag; Laura Pala; Duvaraka Kula-Alwar; John F Mulvey; Du Luping; Timothy E Beach; Lee M Booty; Andrew R Hall; Angela Logan; Volha Sauchanka; Stuart T Caldwell; Ellen L Robb; Andrew M James; Zhelong Xu; Kourosh Saeb-Parsy; Richard C Hartley; Michael P Murphy; Thomas Krieg
Journal:  Cardiovasc Drugs Ther       Date:  2020-07-09       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.